Sequencing Guides Cancer Treatment, but Illustrates Need for Regulatory and Ethical Framework

"We and others are getting close to thinking about doing this work in real time, but [the regulatory issues] haven't been solved yet," Timothy Ley, associate director of Wash U's Genome Institute, told Clinical Sequencing News. "It needs to be solved quickly."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.